BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 378931)

  • 1. Types of beta-lactamase determined by plasmids in gram-negative bacteria.
    Matthew M; Hedges RW; Smith JT
    J Bacteriol; 1979 Jun; 138(3):657-62. PubMed ID: 378931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.
    Paul GC; Gerbaud G; Bure A; Philippon AM; Pangon B; Courvalin P
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1958-63. PubMed ID: 2692515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
    Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporins.
    Labia R; Morand A; Tiwari K; Sirot J; Sirot D; Petit A
    Rev Infect Dis; 1988; 10(4):885-91. PubMed ID: 3055180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of the beta-lactamase specified by the Pseudomonas plasmid RPL11.
    Matthew M; Sykes RB
    J Bacteriol; 1977 Oct; 132(1):341-5. PubMed ID: 410783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the plasmid mediated beta-lactamase BIL-1.
    Payne DJ; Woodford N; Amyes SG
    J Antimicrob Chemother; 1992 Aug; 30(2):119-27. PubMed ID: 1399921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic properties of two plasmid-mediated beta-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins.
    Labia R; Morand A; Tiwari K; Pitton JS; Sirot D; Sirot J
    J Antimicrob Chemother; 1988 Mar; 21(3):301-7. PubMed ID: 3283096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five novel plasmid-determined beta-lactamases.
    Medeiros AA; Cohenford M; Jacoby GA
    Antimicrob Agents Chemother; 1985 May; 27(5):715-9. PubMed ID: 3925874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of cefdinir (C1-983, FK482) to extended-spectrum plasmid-mediated beta-lactamases.
    Payne DJ; Amyes SG
    J Med Microbiol; 1993 Feb; 38(2):114-7. PubMed ID: 8429536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and distribution of R plasmid mediated beta-lactamases in Enterobacteriaceae.
    Pagani L; Perduca M; Romero E
    Microbiologica; 1982 Jul; 5(3):179-84. PubMed ID: 6750326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins.
    Matsumoto Y; Ikeda F; Kamimura T; Yokota Y; Mine Y
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1243-6. PubMed ID: 3056257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular hybridization versus isoelectric focusing to determine TEM-type beta-lactamases in gram-negative bacteria.
    Jouvenot M; Deschaseaux ML; Royez M; Mougin C; Cooksey RC; Michel-Briand Y; Adessi GL
    Antimicrob Agents Chemother; 1987 Feb; 31(2):300-5. PubMed ID: 3551834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli.
    Nordmann P; Mariotte S; Naas T; Labia R; Nicolas MH
    Antimicrob Agents Chemother; 1993 May; 37(5):939-46. PubMed ID: 8517720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transfer of plasmid beta-lactamases in enterobacteria].
    Umaran A; Garaizar J; Gallego L; Colom K; Cisterna R
    Enferm Infecc Microbiol Clin; 1989 Apr; 7(4):189-94. PubMed ID: 2490696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations altering substrate specificity in OHIO-1, and SHV-1 family beta-lactamase.
    Shlaes DM; Currie-McCumber C
    Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):411-5. PubMed ID: 1599426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA; Hare R; Papa E; Adam C; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
    Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli.
    Silva J; Aguilar C; Ayala G; Estrada MA; Garza-Ramos U; Lara-Lemus R; Ledezma L
    Antimicrob Agents Chemother; 2000 Apr; 44(4):997-1003. PubMed ID: 10722503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.